* NU Skin Enterprises Inc NUS.N NUS is expected to show
a fall
in quarterly revenue when it reports results on May 3.
* The Provo Utah-based company is expected to report a
21.1% decrease in revenue to $477.477 million from $604.9
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. The company's guidance on
February 15 2023, for the period ended March 31, was for revenue
between $450.00 million and $490.00 million.
* Refinitiv's mean analyst estimate for NU Skin Enterprises
Inc
is for earnings of 33 cents per share. The company's EPS
guidance on February 15 2023, for the period ended March 31, was
between $0.25 and $0.35
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NU Skin
Enterprises Inc is $40, below its last closing price
of $40.04.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.53 0.53 0.89 Beat 66.4
Sep. 30 2022 0.78 0.78 0.47 Missed -39.6
Jun. 30 2022 0.76 0.75 0.77 Beat 2.3
Mar. 31 2022 0.72 0.72 0.76 Beat 5.8
Dec. 0.95 0.95 1.11 Beat 17.3
31 2021
Sep. 30 2021 0.88 0.86 0.97 Beat 12.9
Jun. 30 2021 1.06 1.05 1.15 Beat 10
Mar. 31 2021 0.73 0.72 0.91 Beat 26
This summary was machine generated May 2 at 02:06 GMT. All
figures in US dollars unless otherwise stated